Streck

Executive Summary

Streck is a privately held diagnostics company based in Omaha, Nebraska, with over 50 years of experience in developing and manufacturing products for hematology, immunology, molecular diagnostics, cell stabilization, and infectious diseases. The company serves clinical and research laboratories worldwide, offering a range of reagents, controls, and kits that are critical for accurate diagnostic testing. Streck's proprietary cell stabilization technology is a key differentiator, enabling reliable sample transport and preservation. While the company does not disclose financials, its long-standing presence and niche expertise position it as a stable player in the diagnostics market. Recent trends in liquid biopsy and precision medicine present growth opportunities, but Streck faces competition from larger diagnostics firms and must continuously innovate to maintain its edge. The company's private status limits visibility into its specific growth trajectory, but its foundational technology and established customer base provide resilience.

Upcoming Catalysts (preview)

• Q2 2026FDA Clearance or CE Mark for New Liquid Biopsy Stabilization Tube70% success
• Q4 2026Partnership with Major Lab Network for Cell-Free DNA Collection60% success
• Q1 2027Launch of Next-Generation Hematology Control Product80% success